Posted 3/11/2024, 4:30:00 PM
Glycated Albumin Test Market Set to Surge on Rising Diabetes and Personalized Medicine Demand
- US market for glycated albumin tests expected to grow at 8.7% annually through 2034, driven by rising diabetes patients and personalized medicine
- Market size projected to reach $504 million by 2034, up from $223.9 million in 2024
- Recent improvements aim to increase accuracy of glycated albumin readings through enzymatic removal of endogenous interfering substances
- Glycated albumin useful as short- to medium-term indicator of glycemic control compared to HbA1c, reflects postprandial spikes
- Key players developing strategic partnerships to expand production and meet rising demand for glycated albumin assays